Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction [corrected] [published erratum appears in CRIT CARE MED 2008 Oct;36(10):2966].

Saved in:
Bibliographic Details
Title: Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction [corrected] [published erratum appears in CRIT CARE MED 2008 Oct;36(10):2966].
Authors: Fuhrmann JT (AUTHOR), Schmeisser A (AUTHOR), Schulze MR (AUTHOR), Wunderlich C (AUTHOR), Schoen SP (AUTHOR), Rauwolf T (AUTHOR), Weinbrenner C (AUTHOR), Strasser RH (AUTHOR)
Source: Critical Care Medicine. Aug2008, Vol. 36 Issue 8, p2257-2266. 10p.
Database: Academic Search Ultimate
Description
ISSN:00903493
DOI:10.1097/ccm.0b013e3181809846